Type 1 Diabetes
An opportunity to improve patient care
We believe early identification of Type 1 Diabetes can significantly improve patient care—and Labcorp can provide the answers you need.
T1D is an autoimmune disease characterized by the body’s attack on pancreatic β-cells that eventually leads to inability to produce insulin. As a result, T1D can progress silently—for months or even years before the onset of symptoms. Patients at-risk for clinical T1D may not be aware of their condition, which is often associated with family history and genetic factors. Patients can learn more about Type 1 Diabetes here.
Research shows that at least 1.6 million people in the U.S. ¹(18 million globally) live with T1D, and the prevalence is increasing. Another estimated 300K people are at increased risk² of clinical T1D in the U.S.